BioVentrix’s Revivent TC Ventricular Enhancement System Receives CE Mark Approval


June 27, 2016—BioVentrix Inc. announced that it has received European CE Mark approval for its Revivent TC transcatheter ventricular enhancement system. Revivent TC system is used after a myocardial infarction to implant microanchor pairs to exclude scarred myocardium from the healthy tissue of the left ventricle (LV). The restoration of the LV to a more optimal volume and conical shape has proven to enhance cardiac performance and significantly improve a patient's quality of life, noted the company.

According to BioVentrix, the Revivent TC system and its placement with the LIVE (Less Invasive Ventricular Enhancement) procedure obviates the need for more invasive surgery. In the procedure, small titanium anchors are placed along the outer surface of the heart and along one of the interior walls via a closed-chest endovascular approach. The anchors are then pulled toward one another, effectively excluding the scarred and nonfunctioning heart wall. As a result of the exclusion, ventricular volume is immediately reduced by as much as 30% to 40%.

At 2-year follow-up, patients demonstrated a 38% improvement in quality of life. Additionally, treatment has been shown to extend life for patients with a significant reduction of 31% in LV end-systolic volume index and a 23% improvement in LV ejection fraction, stated BioVentrix.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.